Detalhe da pesquisa
1.
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
Lung
; 198(1): 201-206, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897594
2.
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
Radiat Oncol
; 15(1): 148, 2020 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517716
3.
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy.
Transl Lung Cancer Res
; 9(3): 541-548, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676318
4.
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Radiat Oncol
; 15(1): 5, 2020 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898519
5.
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.
Anticancer Res
; 39(9): 5077-5081, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519618
6.
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.
Transl Lung Cancer Res
; 8(5): 593-604, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31737496